Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia Patients Treated with Tisagenlecleucel
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Michael A. Pulsipher, Xia Han, Máire Quigley, Gabor Kari, Susana Rives, Theodore W. Laetsch, Gary Douglas Myers, Hidefumi Hiramatsu, Gregory A. Yanik, Muna Qayed, Timothy Driscoll, Michael W. Boyer, Heather Stefanski, Jochen Büchner, Andre Baruchel, Peter Bader, Lan Yi, Creton Kalfoglou, Harlan Robins, Erik Yusko, Güllü Görgün, Eric Bleickardt, Stephane Wong, Stephan A. Grupp
Institutions: University of Southern California, Children's Hospital of Los Angeles, Hospital Sant Joan de Déu Barcelona, The University of Texas Southwestern Medical Center, Children's Mercy Hospital, Kyoto University, C. S. Mott Children's Hospital, Emory University, Duke University, Duke Medical Center, University of Utah, University of Minnesota, Oslo University Hospital, Hôpital Robert-Debré, University Hospital Frankfurt, Fred Hutch Cancer Center, Adaptive Biotechnologies (United States), Children's Hospital of Philadelphia, University of Pennsylvania
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2908415702